Offshore investing - Allan Gray
Featured article

Orbis Global Equity: Biotech breakthroughs in a crowded market

In an increasingly competitive and crowded market, the biotech sector offers unique opportunities to capitalise on overlooked, undervalued shares. Graeme Forster and Mo Zhao from our offshore partner, Orbis, highlight cutting-edge companies within the sector, indicating how the Orbis Global Equity Fund is positioned to benefit from long-term innovation and breakthroughs in biotech.

Read more
Filter by:

Uncategorised

No results

There are currently no insights that match your filter. You may try selecting different filters, or alternatively clear filters.

Select a site

The financial services, products or investments referred to on this website are not available to persons resident in jurisdictions where their availability or distribution would contravene local laws or regulations and the information on this website is not intended for use by these persons. This website is for information only and does not in any way constitute a solicitation or offer by Allan Gray Proprietary Limited or any of its associates or subsidiaries (collectively “Allan Gray”) to buy or sell any financial instruments or to provide any investment advice or service.

By selecting one of the countries below I confirm that I have read and understood the above and that:

(a) I am not a South African citizen; or 
(b) I do not reside in the Republic of South Africa; or 
(c) I am not otherwise a person to whom the communication of the information contained in this website is prohibited by the laws of my home jurisdiction; and 
(d) I am not acting for the benefit of any such persons mentioned in (a),(b) and (c) and 
(e) I confirm that any investment with Allan Gray is based on my own initiative and not due to any offer or solicitation by Allan Gray.

Australia Namibia Botswana South Africa
Cookies

Please refer to our Cookie Policy for detailed information on the cookies we use and the purposes for which we use them.

Close